Article Information
History
- August 20, 2024.
Article Versions
- You are currently viewing Version 1 of this article (August 20, 2024 - 10:01).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Joseph R. Friedman, MD, PhD, MPH1,2,*,
- Alejando González Montoya, MD3,
- Carmina Ruiz3,
- Mariana Alejandra González Tejeda, RN3,
- Luis A. Segovia, BS3,
- Morgan E. Godvin, BS4,
- Edward Sisco, PhD5,
- Elise M. Pyfrom, BS5,
- Meghan G. Appley, PhD5,
- Chelsea Shover, PhD4 and
- Lilia Pacheco Bufanda, MS3,6,*
- 1Department of Psychiatry, University of California, San Diego
- 2Asociación Bajacaliforniana de Salud Pública A.C., Tijuana, Baja California, México
- 3Prevencasa, A.C., Tijuana, México
- 4University of California, Los Angeles
- 5National Institute of Standards and Technology, Gaithersburg, MD
- 6Xochicalco University, Tijuana, Mexico
- ↵*Correspondence to joseph.robert.friedman{at}gmail.com and liliapacheco{at}prevencasa.org
Posted August 20, 2024.
The Detection of Xylazine in Tijuana, Mexico: Triangulating Drug Checking and Clinical Urine Testing Data
